RBA Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,823
Closed -$391K 93
2023
Q4
$391K Sell
4,823
-375
-7% -$29.2K 0.17% 66
2023
Q3
$390K Sell
5,198
-410
-7% -$31.5K 0.19% 64
2023
Q2
$432K Sell
5,608
-179
-3% -$14.3K 0.2% 63
2023
Q1
$480K Sell
5,787
-350
-6% -$29K 0.24% 61
2022
Q4
$527K Sell
6,137
-178
-3% -$14.1K 0.28% 60
2022
Q3
$390K Sell
6,315
-1,699
-21% -$107K 0.22% 62
2022
Q2
$495K Sell
8,014
-795
-9% -$49.2K 0.27% 61
2022
Q1
$524K Sell
8,809
-512
-5% -$32.7K 0.25% 64
2021
Q4
$677K Buy
+9,321
New +$642K 0.32% 64
2021
Q2
Sell
-10,164
Closed -$657K 132
2021
Q1
$657K Sell
10,164
-450
-4% -$29K 0.56% 45
2020
Q4
$618K Sell
10,614
-2,625
-20% -$158K 0.37% 70
2020
Q3
$837K Sell
13,239
-2,413
-15% -$167K 0.57% 59
2020
Q2
$1.2M Sell
15,652
-1,070
-6% -$82K 0.88% 45
2020
Q1
$1.25M Sell
16,722
-1,327
-7% -$91.7K 1.08% 37
2019
Q4
$1.17M Sell
18,049
-1,098
-6% -$71.5K 0.8% 45
2019
Q3
$1.21M Sell
19,147
-1,181
-6% -$77.2K 0.93% 44
2019
Q2
$1.37M Sell
20,328
-1,132
-5% -$74.5K 1.06% 44
2019
Q1
$1.45M Buy
+21,460
New +$1.43M 1.13% 42

Other funds holding GILD

RBA Wealth Management's GILD Position: Q1 2024 in Review

RBA Wealth Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 4,823 shares — an estimated $391K sold.

RBA Wealth Management first reported a position in GILD in Q1 2019 and held it in 18 quarters. The position peaked at $1.45M in Q1 2019. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • RBA Wealth Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • RBA Wealth Management sold 4,823 Gilead Sciences shares in Q1 2024, an estimated $391K.
  • RBA Wealth Management first reported a position in Gilead Sciences in Q1 2019 and held it in 18 quarters.
  • RBA Wealth Management's Gilead Sciences position peaked at $1.45M in Q1 2019.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on RBA Wealth Management's 13F filing for Q1 2024, filed 19 Apr 2024.